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with the argument that considering RT‐PCR as gold standard when evaluating a new test will inevitably
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With great interest we read the article from Dramé et al. 1 “Should RT-PC be considered 
as gold standard in the diagnosis of Covid-19” questioning the conclusions from 
Cassaniti et al. 2. We agree with the argument that considering RT-PCR as gold standard 
when evaluating a new test will inevitably lead to biased test accuracy estimates of the 
new test 1. However, we disagree that it is impossible to “demonstrate that a new test 
might be better than the old-test” and propose using Bayesian latent class models 
(BLCMs) to estimate the sensitivity and specificity in the absence of a gold standard. 
“Latent” means here that the true disease/infection status is not observed, but can be 
estimated from the data. BLCMs have been applied widely, reporting guidelines have 
been developed 3, and currently an EU-funded initiative aims to expand their application 
in the evaluation of diagnostic tests (www.harmony-net.eu). 
For show-casing BLCMs we used the data from Cassaniti et al. 2, although the keys to 
validity in diagnostic test studies are not respected, i.e. “a consecutive series of patients 
suspected (but not known) to have the target disorder” 4 - which precludes the 
generalisability of the findings. We considered a model with three tests for the diagnosis 
of COVID-19 in one population (110 patients), and extracted the following data of 
cross-classified test results (RT-PCR, IgG and IgM) 2: +++ 28, ++- 1, +-+ 3, +-- 36, -
++ 0, -+- 0, --+ 1, --- 41. We aim to estimate the prevalence, the sensitivities and the 
specificities of three tests, and potential conditional dependencies (correlations) 
between tests. Since the maximum number of estimable parameters for three tests in 
one population is seven 5, this model is not identifiable. Therefore, in a Bayesian 
framework, we rely on prior information for the specificities of all three tests similar to 
a previous analysis with two tests and four populations 6. We assume that they are close 
to 100%. Further technical details about the model and Markov Chain Monte Carlo 
simulation, including the code to reproduce the results, are available on 
 














(https://github.com/shartn/BLCM-COVID19). In Table 1 the posteriors resulting from 
a model with conditional dependency between the IgG and IgM test sensitivities are 
displayed. 
In contrast to the previous analysis 2, which used RT-PCR as a gold standard, implicitly 
assuming 100% sensitivity and specificity, the RT-PCR sensitivity based on our BLCM 
analysis is lower, while the specificity of all three tests is close to 100%. The estimated 
sensitivity of the combined IgM/IgG in the study from Cassaniti et al. 2 was 18.4%, 
being outside the 95% probability interval of our BLCM estimates for both the IgM and 
IgG. Although, based on our BLCM analysis, we cannot state “that the new test might 
be better” 1, we are confident that BLCMs allow estimation of sensitivities and 
specificities in an unbiased way without needing a gold standard. Since this data set - 
with the exception of the 50 emergency patients - does not comply with the key aspects 
of validity 4, it is not possible to generalise the results of our BLCM beyond the study 
population of the 110 patients.  
Despite enormous COVID-19 research activities, the application of BLCMs and 
suitable data sets are virtually absent. For the preparedness of future pandemics, we 
suggest to include the design of appropriate diagnostic test accuracy studies, which will 
also be suitable for BLCMs. 
  
 














Table 1 - Posterior medians and 95% probability intervals for the sensitivities and 
specificities of three tests, prevalence and the correlation between the sensitivities of 
the IgM and the IgG test resulting from BLCM analysis 
Parameter Posterior median 
(95% Probability interval) 
Prevalence 87.9 
(72.2;99.0) 
RT-PCR Sensitivity 55.2 
(49.7;65.6) 
RT-PCR Specificity 99.0 
(97.7;99.7) 
IgG Sensitivity 31.3 
(21.9;42.4) 
IgG Specificity 98.2 
(94.8;99.6) 
IgM Sensitivity 33.2 
(23.8;44.1) 
IgM Specificity 98.1 
(94.4;99.6) 
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